{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:35:28Z","timestamp":1793327728340,"version":"4.5.0"},"reference-count":15,"publisher":"Scientific Scholar","issue":"04","license":[{"start":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T00:00:00Z","timestamp":1675641600000},"content-version":"vor","delay-in-days":128,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["South Asian J Cancer"],"published-print":{"date-parts":[[2022,10]]},"abstract":"<jats:p>Objective\u2003The study aimed to see the clinical outcome and to identify prognostic factors for survival in patients with carcinoma endometrium.<\/jats:p>\n                  <jats:p>Methods\u2003Patients registered at Regional Cancer Centre, Thiruvananthapuram, Kerala, India, with carcinoma endometrium from January 2009 to December 2013 were identified from hospital registry. Data regarding patient demographics, tumor characteristics, treatment schedules, and follow-up were collected using a structured proforma. Survival estimates were generated using the Kaplan\u2013Meier method. Univariate analysis was done using chi-square and Fisher's exact tests. Multivariate analysis using the Cox regression model was performed to determine the impact of prognostic factors on outcome. The statistical analysis was done using SPSS software version 11.<\/jats:p>\n                  <jats:p>Results\u2003The median follow-up of the 686 patients was 95 months (range 3\u2013178 months).There were 432 stage 1 (63%), 100 stage II (14.6%), 108 stage III (15.7%), and 46 stage IV patients (6.7%). The 5-year overall survival was 89.2%. Prognostic factors for survival on univariate analysis were age 60 years or older, nonendometrioid histology, high-grade tumor, cervical stromal involvement, para-aortic node involvement, negative progesterone receptor expression, deep myometrial invasion advanced stage, surgery versus no surgery, serosal involvement, and ovarian and fallopian tube involvement. However, on multivariate analysis, age over 60 years, higher histological grade, advanced stage, and deep myometrial and parametrial invasion were associated with significantly poorer survival.<\/jats:p>\n                  <jats:p>Conclusion\u2003We found that age over 60 years at presentation, higher grade, advanced stage, deep myometrial invasion, and parametrial invasion were associated with poorer survival.<\/jats:p>","DOI":"10.1055\/s-0041-1735563","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T18:31:12Z","timestamp":1675708272000},"page":"309-314","source":"Crossref","is-referenced-by-count":1,"title":["Prognostic Factors for Survival in Patients with Carcinoma Endometrium"],"prefix":"10.25259","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0059-4323","authenticated-orcid":false,"given":"Aparna Mullangath","family":"Prakasan","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0521-3374","authenticated-orcid":false,"given":"Minolin","family":"Dhas","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishnapillai M.","family":"Jagathnathkrishna","sequence":"additional","affiliation":[{"name":"Department of Biostatistics and Epidemiology, Regional Cancer Centre, Thiruvananthapuram, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8794-1975","authenticated-orcid":false,"given":"Aswin","family":"Kumar","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3344-820X","authenticated-orcid":false,"given":"Susan","family":"Mathews","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Joseph","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8128-0363","authenticated-orcid":false,"given":"Suchetha","family":"Sambasivan","sequence":"additional","affiliation":[{"name":"Division of Gynecological Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0556-4492","authenticated-orcid":false,"given":"Francis V.","family":"James","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Regional Cancer Center, Thiruvananthapuram, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2023,2,6]]},"reference":[{"issue":"01","key":"ref1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/CEJ.0b013e3283410166","article-title":"Increase in incidence of cancer of corpus uteri: estimation of time trends\u2014an Indian scenario","volume":"20","author":"N S Murthy","year":"2011","journal-title":"Eur J Cancer Prev"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1002\/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8","article-title":"Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study","volume":"60","author":"W T Creasman","year":"1987","journal-title":"Cancer"},{"issue":"03","key":"ref3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.ijrobp.2014.11.022","article-title":"Nomograms for prediction of outcome with or without adjuvant radiation therapy for patients with endometrial cancer: a pooled analysis of PORTEC-1 and PORTEC-2 trials","volume":"91","author":"C L Creutzberg","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"03","key":"ref4","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.3802\/jgo.2019.30.e44","article-title":"Survival outcomes of adjuvant radiotherapy and chemotherapy in women with stage I serous papillary and clear cell carcinoma of the endometrium: a Korean multicenter study","volume":"30","author":"M Kim","year":"2019","journal-title":"J Gynecol Oncol"},{"issue":"03","key":"ref5","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1097\/IGC.0000000000001187","article-title":"Added value of estrogen receptor, progesterone receptor, and L1 cell adhesion molecule expression to histology-based endometrial carcinoma recurrence prediction models: an ENITEC collaboration study","volume":"28","author":"L JM van der Putten","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0140-6736(09)62163-2","article-title":"Vaginal brachytherapy versus pelvic external beam radiotherapy for patients with endometrial cancer of high-intermediate risk (PORTEC-2): an open-label, non-inferiority, randomised trial","volume":"375","author":"R A Nout","year":"2010","journal-title":"Lancet"},{"issue":"03","key":"ref7","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/j.ygyno.2003.11.048","article-title":"A phase III trial of surgery with or without adjunctive external pelvic radiation therapy in intermediate risk endometrial adenocarcinoma: a gynecologic oncology group study","volume":"92","author":"H M Keys","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"02","key":"ref8","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1080\/00016340701876163","article-title":"Prognostic factors for recurrence in patients with FIGO stage I and II, intermediate or high risk endometrial cancer","volume":"87","author":"P L Zusterzeel","year":"2008","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"01","key":"ref9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.ygyno.2011.02.040","article-title":"Endometrial cancer in the oldest old: tumor characteristics, patterns of care, and outcome","volume":"122","author":"J D Wright","year":"2011","journal-title":"Gynecol Oncol"},{"issue":"05","key":"ref10","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/IGC.0000000000000970","article-title":"Prediction of site-specific tumor relapses in patients with stage I-II endometrioid endometrial cancer","volume":"27","author":"T Tuomi","year":"2017","journal-title":"Int J Gynecol Cancer"},{"issue":"01","key":"ref11","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/IGC.0000000000000609","article-title":"ESMO-ESGO-ESTRO consensus conference on endometrial cancer: diagnosis, treatment and follow-up","volume":"26","author":"N Colombo","year":"2016","journal-title":"Int J Gynecol Cancer"},{"issue":"05","key":"ref12","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/AOG.0b013e3181f39849","article-title":"Comparative performance of the 2009 International Federation of Gynecology and Obstetrics' staging system for uterine corpus cancer","volume":"116","author":"S N Lewin","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"05","key":"ref13","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1097\/AOG.0b013e3181f98202","article-title":"Predicting parametrial involvement in endometrial cancer: is this the end for radical hysterectomies in stage II endometrial cancers?","volume":"116","author":"P J Disaia","year":"2010","journal-title":"Obstet Gynecol"},{"issue":"02","key":"ref14","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.ygyno.2015.09.001","article-title":"Canadian high risk endometrial cancer (CHREC) consortium: analyzing the clinical behavior of high risk endometrial cancers","volume":"139","author":"A D Altman","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"05","key":"ref15","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/PAS.0000000000001020","article-title":"Molecular classification of grade 3 endometrioid endometrial cancers identifies distinct prognostic subgroups","volume":"42","author":"T Bosse","year":"2018","journal-title":"Am J Surg Pathol"}],"container-title":["South Asian Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-0041-1735563.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T11:12:34Z","timestamp":1781176354000},"score":1,"resource":{"primary":{"URL":"https:\/\/journal.sajc.org\/prognostic-factors-for-survival-in-patients-with-carcinoma-endometrium\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":15,"journal-issue":{"issue":"04","published-online":{"date-parts":[[2023,2,6]]},"published-print":{"date-parts":[[2022,10]]}},"URL":"https:\/\/doi.org\/10.1055\/s-0041-1735563","archive":["Portico","CLOCKSS"],"relation":{},"ISSN":["2278-330X","2278-4306"],"issn-type":[{"value":"2278-330X","type":"print"},{"value":"2278-4306","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10]]}}}